BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 27614436)

  • 1. Levosimendan, a new therapeutic approach to prevent delayed cerebral vasospasm after subarachnoid hemorrhage?
    Konczalla J; Wanderer S; Mrosek J; Gueresir E; Schuss P; Platz J; Seifert V; Vatter H
    Acta Neurochir (Wien); 2016 Nov; 158(11):2075-2083. PubMed ID: 27614436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levosimendan Reduces Prostaglandin F2a-dependent Vasoconstriction in Physiological Vessels and After Experimentally Induced Subarachnoid Hemorrhage.
    Wanderer S; Mrosek J; Gessler F; Seifert V; Konczalla J
    Curr Neurovasc Res; 2018; 15(1):72-80. PubMed ID: 29595109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan as a therapeutic strategy to prevent neuroinflammation after aneurysmal subarachnoid hemorrhage?
    Wanderer S; Andereggen L; Mrosek J; Kashefiolasl S; Schubert GA; Marbacher S; Konczalla J
    J Neurointerv Surg; 2022 Apr; 14(4):408-412. PubMed ID: 34039684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional effects of levosimendan in rat basilar arteries in vitro.
    Konczalla J; Mrosek J; Wanderer S; Schuss P; Guresir E; Seifert V; Vatter H; Platz J
    Curr Neurovasc Res; 2013 May; 10(2):126-33. PubMed ID: 23469954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of levosimendan in the treatment of cerebral vascular vasospasm: a case study.
    Onichimowski D; Nosek K; Goraj R; Jalali R; Wińska A; Pawlos A; Tuyakov B
    Drug Des Devel Ther; 2018; 12():1777-1783. PubMed ID: 29950812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of levosimendan on cerebral vasospasm induced by subarachnoid haemorrhage: an experimental study.
    Cengiz SL; Erdi MF; Tosun M; Atalik E; Avunduk MC; Sönmez FC; Mehmetoglu I; Baysefer A
    Brain Inj; 2010; 24(6):877-85. PubMed ID: 20433288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between the angiotensin and endothelin system in the cerebrovasculature after experimental induced subarachnoid hemorrhage.
    Wanderer S; Mrosek J; Vatter H; Seifert V; Konczalla J
    Neurosurg Rev; 2018 Apr; 41(2):539-548. PubMed ID: 28756589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasomodulatory effects of the angiotensin II type 1 receptor antagonist losartan on experimentally induced cerebral vasospasm after subarachnoid haemorrhage.
    Wanderer S; Mrosek J; Gessler F; Seifert V; Konczalla J
    Acta Neurochir (Wien); 2018 Feb; 160(2):277-284. PubMed ID: 29214400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Losartan as a Potential Neuroregenerative Pharmacological Agent after Aneurysmal Subarachnoid Haemorrhage.
    Wanderer S; Andereggen L; Mrosek J; Kashefiolasl S; Marbacher S; Konczalla J
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in neurological outcome and abolition of cerebrovascular endothelin B and 5-hydroxytryptamine 1B receptor upregulation through mitogen-activated protein kinase kinase 1/2 inhibition after subarachnoid hemorrhage in rats.
    Larsen CC; Povlsen GK; Rasmussen MN; Edvinsson L
    J Neurosurg; 2011 Apr; 114(4):1143-53. PubMed ID: 20597604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm.
    Zuccarello M; Boccaletti R; Romano A; Rapoport RM
    Stroke; 1998 Sep; 29(9):1924-9. PubMed ID: 9731620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous intravenous infusion of CGS 26303, an endothelin-converting enzyme inhibitor, prevents and reverses cerebral vasospasm after experimental subarachnoid hemorrhage.
    Kwan AL; Lin CL; Chang CZ; Wu HJ; Hwong SL; Jeng AY; Lee KS
    Neurosurgery; 2001 Aug; 49(2):422-7; discussion 427-9. PubMed ID: 11504119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetramethylpyrazine Nitrone Reduces Oxidative Stress to Alleviate Cerebral Vasospasm in Experimental Subarachnoid Hemorrhage Models.
    Wu L; Su Z; Zha L; Zhu Z; Liu W; Sun Y; Yu P; Wang Y; Zhang G; Zhang Z
    Neuromolecular Med; 2019 Sep; 21(3):262-274. PubMed ID: 31134485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function.
    Vatter H; Konczalla J; Weidauer S; Preibisch C; Zimmermann M; Raabe A; Seifert V
    J Neurosurg; 2007 Jul; 107(1):121-7. PubMed ID: 17639881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.
    Matsuda N; Ohkuma H; Naraoka M; Munakata A; Shimamura N; Asano K
    J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17beta-estradiol inhibits endothelin-1 production and attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.
    Lin CL; Dumont AS; Wu SC; Wang CJ; Howng SL; Huang YF; Wong WY; Kassell NF; Jeng AY; Kwan AL
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1054-7. PubMed ID: 16741048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the Ca++-permeable nonselective cation channel blocker LOE 908 on subarachnoid hemorrhage-induced vasospasm in the basilar artery in rabbits.
    Kawanabe Y; Masaki T; Hashimoto N
    J Neurosurg; 2003 Mar; 98(3):561-4. PubMed ID: 12650428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the endothelin-B receptor expression and vasomotor function during experimental cerebral vasospasm.
    Vatter H; Konczalla J; Weidauer S; Preibisch C; Raabe A; Zimmermann M; Seifert V
    Neurosurgery; 2007 Jun; 60(6):1100-8; discussion 1108-9. PubMed ID: 17538385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of an inhibitor of endothelin-converting enzyme attenuates cerebral vasospasm following experimental subarachnoid haemorrhage in rabbits.
    Kwan AL; Lin CL; Chang CZ; Winardi D; Yen CP; Wu SC; Lee KS; Kassell NF; Howng SL; Savage P; Jeng AY
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():414S-417S. PubMed ID: 12193135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of mexiletine for attenuation of cerebral vasospasm following experimental subarachnoid haemorrhage.
    Caner H; Kwan AL; Bavbek M; Kilinc K; Durieux M; Lee K; Kassell NF
    Acta Neurochir (Wien); 2000; 142(4):455-61. PubMed ID: 10883344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.